Sakai I - Search Results

1

Characterization of four different mammalian-cell-derived recombinant human interferon-beta 1s. Identical polypeptides and non-identical carbohydrate moieties compared to natural ones.

Utsumi J, Mizuno Y, Hosoi K, Okano K, Sawada R, Kajitani M, Sakai I, Naruto M, Shimizu H. Utsumi J, et al. Among authors: sakai i. Eur J Biochem. 1989 May 15;181(3):545-53. doi: 10.1111/j.1432-1033.1989.tb14758.x. Eur J Biochem. 1989. PMID: 2731537 Free article.

2

Geranylgeraniol is a potent inducer of apoptosis in tumor cells.

Ohizumi H, Masuda Y, Nakajo S, Sakai I, Ohsawa S, Nakaya K. Ohizumi H, et al. Among authors: sakai i. J Biochem. 1995 Jan;117(1):11-3. doi: 10.1093/oxfordjournals.jbchem.a124695. J Biochem. 1995. PMID: 7775375 Free article.

3

Geranylgeraniol causes a decrease in levels of calreticulin and tyrosine phosphorylation of a 36-kDa protein prior to the appearance of apoptotic features in HL-60 cells.

Nakajo S, Okamoto M, Masuda Y, Sakai I, Ohsawa S, Nakaya K. Nakajo S, et al. Among authors: sakai i. Biochem Biophys Res Commun. 1996 Sep 24;226(3):741-5. doi: 10.1006/bbrc.1996.1423. Biochem Biophys Res Commun. 1996. PMID: 8831684

4

Induction of apoptosis in various tumor cell lines by geranylgeraniol.

Ohizumi H, Masuda Y, Yoda M, Hashimoto S, Aiuchi T, Nakajo S, Sakai I, Ohsawa S, Nakaya K. Ohizumi H, et al. Among authors: sakai i. Anticancer Res. 1997 Mar-Apr;17(2A):1051-7. Anticancer Res. 1997. PMID: 9137448

5

Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines.

Sakai I, Hashimoto S, Yoda M, Hida T, Ohsawa S, Nakajo S, Nakaya K. Sakai I, et al. Biochem Biophys Res Commun. 1994 Dec 15;205(2):1305-10. doi: 10.1006/bbrc.1994.2807. Biochem Biophys Res Commun. 1994. PMID: 7802663

6

Geranylgeranylacetone used as an antiulcer agent is a potent inducer of differentiation of various human myeloid leukemia cell lines.

Sakai I, Tanaka T, Osawa S, Hashimoto S, Nakaya K. Sakai I, et al. Biochem Biophys Res Commun. 1993 Mar 31;191(3):873-9. doi: 10.1006/bbrc.1993.1298. Biochem Biophys Res Commun. 1993. PMID: 8466527

7

Sensitivity to interferon-alpha and interferon-stimulated gene factor 3 binding activity in human chronic myelogenous leukemia cell line KT-1.

Yamauchi H, Sakai I, Narumi H, Soga S, Fujita S. Yamauchi H, et al. Among authors: sakai i. Acta Haematol. 2000;104(1):1-9. doi: 10.1159/000041061. Acta Haematol. 2000. PMID: 11111114

8

The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells.

Sakai I, Kraft AS. Sakai I, et al. J Biol Chem. 1997 May 9;272(19):12350-8. doi: 10.1074/jbc.272.19.12350. J Biol Chem. 1997. PMID: 9139679 Free article.

9

Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells.

Sakai I, Takeuchi K, Yamauchi H, Narumi H, Fujita S. Sakai I, et al. Blood. 2002 Oct 15;100(8):2926-31. doi: 10.1182/blood-2002-01-0073. Blood. 2002. PMID: 12351404 Free article.

10

Development of interferon-alpha resistant subline from human chronic myelogenous leukemia cell line KT-1.

Yamauchi H, Sakai I, Narumi H, Takeuchi K, Soga S, Fujita S. Yamauchi H, et al. Among authors: sakai i. Intern Med. 2001 Jul;40(7):607-12. doi: 10.2169/internalmedicine.40.607. Intern Med. 2001. PMID: 11506301 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters